ANI Pharmaceuticals CFO Sells $240k in Stock Following Cortrophin Surge

Stephen Carey, CFO of ANI Pharmaceuticals (ANIP), sold 2,850 shares worth approximately $240,000 on June 29. The sale represented a small portion of his holdings and occurred after the company's stock surged by 42%. This transaction is in line with similar sales over the past year.

By Jonathan Ponciano · Motley Fool ·

ANI Pharmaceuticals CFO Sells $240k in Stock Following Cortrophin Surge

Tickers: $ANIP

Topics: executive sale SEC filing stock transaction

Read the full article at Motley Fool

More World news